Our detailed analysis, utilizing systematic approaches, established that both the expression of STAT3 and the STAT3 signaling activities are strongly associated with higher WHO grades of glioma, the presence of 1p/19q chromosome 1p/19q non-codeletions, and IDH wild-type status. Here, STAT3 is linked to glioma.